Literature DB >> 28039094

PETPVE12: an SPM toolbox for Partial Volume Effects correction in brain PET - Application to amyloid imaging with AV45-PET.

Gabriel Gonzalez-Escamilla1, Catharina Lange2, Stefan Teipel3, Ralph Buchert2, Michel J Grothe4.   

Abstract

Positron emission tomography (PET) allows detecting molecular brain changes in vivo. However, the accuracy of PET is limited by partial volume effects (PVE) that affects quantitative analysis and visual interpretation of the images. Although PVE-correction methods have been shown to effectively increase the correspondence of the measured signal with the true regional tracer uptake, these procedures are still not commonly applied, neither in clinical nor in research settings. Here, we present an implementation of well validated PVE-correction procedures as a SPM toolbox, PETPVE12, for automated processing. We demonstrate its utility by a comprehensive analysis of the effects of PVE-correction on amyloid-sensitive AV45-PET data from 85 patients with Alzheimer's disease (AD) and 179 cognitively normal (CN) elderly. Effects of PVE-correction on global cortical standard uptake value ratios (SUVR) and the power of diagnostic group separation were assessed for the region-wise geometric transfer matrix method (PVEc-GTM), as well as for the 3-compartmental voxel-wise "Müller-Gärtner" method (PVEc-MG). Both PVE-correction methods resulted in decreased global cortical SUVRs in the low to middle range of SUVR values, and in increased global cortical SUVRs at the high values. As a consequence, average SUVR of the CN group was reduced, whereas average SUVR of the AD group was increased by PVE-correction. These effects were also reflected in increased accuracies of group discrimination after PVEc-GTM (AUC=0.86) and PVEc-MG (AUC=0.89) compared to standard non-corrected SUVR (AUC=0.84). Voxel-wise analyses of PVEc-MG corrected data also demonstrated improved detection of regionally increased AV45 SUVR values in AD patients. These findings complement the growing evidence for a beneficial effect of PVE-correction in quantitative analysis of amyloid-sensitive PET data. The novel PETPVE12 toolbox significantly facilitates the application of PVE-correction, particularly within SPM-based processing pipelines. This is expected to foster the use of PVE-correction in brain PET for more widespread use. The toolbox is freely available at http://www.fil.ion.ucl.ac.uk/spm/ext/#PETPVE12.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Amyloid imaging; MRI; PET; Partial Volume Effects correction

Mesh:

Substances:

Year:  2016        PMID: 28039094     DOI: 10.1016/j.neuroimage.2016.12.077

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  53 in total

1.  Association Between Reduced Brain Glucose Metabolism and Cortical Thickness in Alcoholics: Evidence of Neurotoxicity.

Authors:  Dardo G Tomasi; Corinde E Wiers; Ehsan Shokri-Kojori; Amna Zehra; Veronica Ramirez; Clara Freeman; Jamie Burns; Christopher Kure Liu; Peter Manza; Sung W Kim; Gene-Jack Wang; Nora D Volkow
Journal:  Int J Neuropsychopharmacol       Date:  2019-09-01       Impact factor: 5.176

2.  One MRI-compatible tDCS session attenuates ventromedial cortical perfusion when exposed to verbal criticism: The role of perceived criticism.

Authors:  Chris Baeken; Josefien Dedoncker; Jonathan Remue; Guo-Rong Wu; Marie-Anne Vanderhasselt; Sara De Witte; Tasha Poppa; Jill M Hooley; Rudi De Raedt
Journal:  Hum Brain Mapp       Date:  2018-06-28       Impact factor: 5.038

3.  Comparison of Amyloid β and Tau Spread Models in Alzheimer's Disease.

Authors:  Hang-Rai Kim; Peter Lee; Sang Won Seo; Jee Hoon Roh; Minyoung Oh; Jungsu S Oh; Seung Jun Oh; Jae Seung Kim; Yong Jeong
Journal:  Cereb Cortex       Date:  2019-09-13       Impact factor: 5.357

4.  Use of deep learning-based radiomics to differentiate Parkinson's disease patients from normal controls: a study based on [18F]FDG PET imaging.

Authors:  Xiaoming Sun; Jingjie Ge; Lanlan Li; Qi Zhang; Wei Lin; Yue Chen; Ping Wu; Likun Yang; Chuantao Zuo; Jiehui Jiang
Journal:  Eur Radiol       Date:  2022-06-08       Impact factor: 5.315

5.  Cortical β-amyloid burden, gray matter, and memory in adults at varying APOE ε4 risk for Alzheimer's disease.

Authors:  Adam P Mecca; Nicole M Barcelos; Shuo Wang; Anna Brück; Nabeel Nabulsi; Beata Planeta-Wilson; Jennifer Nadelmann; Amanda L Benincasa; Jim Ropchan; Yiyun Huang; Joel Gelernter; Peter H Van Ness; Richard E Carson; Christopher H van Dyck
Journal:  Neurobiol Aging       Date:  2017-10-06       Impact factor: 4.673

Review 6.  Neuroimaging of Alzheimer's disease: focus on amyloid and tau PET.

Authors:  Hiroshi Matsuda; Yoko Shigemoto; Noriko Sato
Journal:  Jpn J Radiol       Date:  2019-09-06       Impact factor: 2.374

7.  Parametric estimation of reference signal intensity in the quantification of amyloid-beta deposition: an 18F-AV-45 study.

Authors:  Min Wang; Zhuangzhi Yan; Huiwei Zhang; Jiaying Lu; Ling Li; Jintai Yu; Jian Wang; Hiroshi Matsuda; Chuantao Zuo; Jiehui Jiang
Journal:  Quant Imaging Med Surg       Date:  2021-01

8.  Voxel-based correlation of 18F-THK5351 accumulation with gray matter structural networks in cognitively normal older adults.

Authors:  Yoko Shigemoto; Daichi Sone; Norihide Maikusa; Yukio Kimura; Fumio Suzuki; Hiroyuki Fujii; Noriko Sato; Hiroshi Matsuda
Journal:  eNeurologicalSci       Date:  2021-04-28

9.  Uncertainty analysis of MR-PET image registration for precision neuro-PET imaging.

Authors:  Pawel J Markiewicz; Julian C Matthews; John Ashburner; David M Cash; David L Thomas; Enrico De Vita; Anna Barnes; M Jorge Cardoso; Marc Modat; Richard Brown; Kris Thielemans; Casper da Costa-Luis; Isadora Lopes Alves; Juan Domingo Gispert; Mark E Schmidt; Paul Marsden; Alexander Hammers; Sebastien Ourselin; Frederik Barkhof
Journal:  Neuroimage       Date:  2021-02-12       Impact factor: 6.556

10.  Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients.

Authors:  Eric D Vidoni; In-Young Choi; Phil Lee; Gregory Reed; Na Zhang; Joseph Pleen; Jonathan D Mahnken; Jonathan Clutton; Annette Becker; Erica Sherry; Rebecca Bothwell; Heidi Anderson; Robert A Harris; William Brooks; Heather M Wilkins; Lisa Mosconi; Jeffrey M Burns; Russell H Swerdlow
Journal:  Alzheimers Dement       Date:  2020-07-27       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.